Normalization of plasma lipid peroxides, adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment

Diabetes Care

Volumn 21, Issue 4, 1998, Pages 487-493

  Desfaits, Anne Cécile ^a   Serri, Omar ^a   Renier, Genevieve ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLICLAZIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPID PEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DOSE RESPONSE; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CATTLE; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 2; E-SELECTIN; ENDOTHELIUM, VASCULAR; GLICLAZIDE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-6; LIPID PEROXIDES; LIPOPOLYSACCHARIDES; MONOCYTES; REFERENCE VALUES; TREATMENT FAILURE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031945885     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.4.487     Document Type: Article

References (52)

1. Chisolm GM, Irwin KC, Penn MS: Lipoprotein oxidation and Lipoprotein-induced cell injury in diabetes. Diabetes 41:61-66, 1992
2. Semenkovich CF, Heinecke JW: The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes 46:327-334, 1997
3. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL: Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity N Engl J Med 320:915-923, 1989
4. Steinbrecher UP, Zhang H, Lougheed M: Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 9:155-168, 1990
5. Heinecke JW: Cellular mechanisms for the oxidative modification of lipoproteins: implication for atherogenesis. Coron Artery Dis 5:205-210, 1994
6. Berliner JA, Territo MC, Sevanian A, Ramin S, Ai Kim J, Bamshad B, Esterson M, Fogelman: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85:1260-1266, 1990
7. Kim JA, Territo MC, Wayner E, Carlos TM, Parhami F, Smith CW, Haberland ME, Fogelman AM, Berliner JA: Partial characterization of leucocyte binding molecules on endothelial cells induced by minimally oxidized LDL Arterioscler Thromb 14:427-433, 1994
8. Fox PL, Chisolm GM, DiCorleto PE: Lipoprotein-mediated inhibition of endothelial cell production of platelet- derived growth factor-like protein depends on free radical lipid peroxidation. J Biol Chem 262:6046-6054, 1987
9. Hamilton TA, Guoping MA, Chisolm GM: Oxidized low-density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages. J Immunol 144:2343-2350, 1990
10. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676- 1685, 1993
11. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K: Lipid peroxide level in plasma of diabetic patients. Biochem Med 21:104-107, 1979
12. Babiy AV, Gebicki JM, Sullivan DR, Willey K: Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochem Pharmacol 43: 995-1000, 1992
13. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhausl W, Wagner OF: Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4313-4317, 1996
14. Ohno Y, Aoki N, Nishimura A: In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α in insulin- dependent diabetes mellitus. J Clin Endocrinol Metab 77:1072-1077, 1993
15. Hussain MJ, Peakman M, Gallati H, Lo SSS, Hawa M, Viberti GC, Watkins PJ, Leslie RDG, Vergani D: Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diobetologia 39:60-69, 1996
16. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM: Reduced tyrosine kinase activity of the insulin receptor in obesity- diabetes: central role of tumor necrosis factor-α. J Clin Invest 94:1543-1549, 1994
17. Chiasson JL, Hamet P, Verdy M: The effect of Diamicron on the secretion and action of insulin. Diabetes Res Clin Pract 14:S47-S52, 1991
18. Jennings PE, Scott NA, Saniabadi AR, Belch JJF: Effects of gliclazide on platelet reactivity and free radicals in type 11 diabetic patients: clinical assessment. Metabolism 41:36-39, 1992
19. Desfaits AC, Serri O, Renier G: Gliclazide decreases cell-mediated low density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism 46:1150-1156, 1997
20. Caruso C, Candore G, Cigna D, DiLorenzo G, Sireci G, Dieli F, Salerno A: Cytokine production in the elderly. Immunol Res 15:84-90, 1996
21. Kelly MK, Brown JM, Thong YK: Neutrophil and monocyte adherence in diabetes mellitus, alcoholic fibrosis, uremia and elderly patients. Int Arch Allergy Appl Immunol 78:132-138, 1985
22. Boyum A: Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest 97:77-89, 1968
23. Hatch FT: Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6:1-68, 1968
24. Mihara M, Uchiyama M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271-278, 1978
25. Csallany AS, Der Guan M, Manwaring JD, Addis PB: Free malondialdehyde determination in tissues by high-performance liquid chromatography. Anal Biochem 142:277-283, 1984
26. Bath PMW, Booth RFG, Hassall DG: Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay. J Immunol Methods 118:59-65, 1989
27. Luo M, O'Brien RC: Antioxidant effects of sulphonylureas (Abstract). Diabetes 45: 123A, 1996
28. Dosquet C, Weill D, Wautier JL: Molecular mechanism of blood monocyte adhesion to vascular endothelial cells. Nouv Rev Hematol 34:555-59, 1992
29. Berliner JA, Territo MC, Sevanian A, Ramin S, Ai Kim J, Bamshad B, Esterson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85:1260-1266, 1990
30. Lehr HA, Becker M, Marklund SL, Hubner C, Arfors KE, Kohlschutter A, Messmer K: Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arteriosder Thromb 12:824-829, 1992
31. Scott NA, Jennings PE, Brown J, Belch JJF: Gliclazide: a general free radical scavenger. Eur J Pharmacol 208:175-177, 1991
32. Setiadi H, Wautier JL, Courillon-Mallet A, Passa P, Caen J: Increased adhesion to fibronectin and Mo-1 expression by diabetic monocytes. J Immunol 138:3230-3234, 1987
33. Weber C, Erl W, Weber PC: Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoproteins is mediated by activation of CD11b. Biochem Biophys Res Commun 206:621-628, 1995
34. Gearing JH, Newman W: Circulating adhesion molecules in disease. Immunol Today 14:506-512, 1993
35. Khan BV Parthasarathy SS, Alexander RW, Medford RM: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95:1262-1270, 1995
36. Ceriello A, dello Russo P, Amstad P, Cerutti P: High glucose induces antioxidant enzymes in human endothelial cells in culture: evidence linking hyperglycemia and oxidative stress. Diabetes 45:471-477, 1996
37. Cominacini L, Pasini AF, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P, Lo Cascio V: Elevated levels of soluble E-selectin in patients with DDM and NIDDM: relation to metabolic control. Diabetologia 38:1122-1124, 1995
38. Cominacini L, Fratta Pasini A, Garbin U, Campagnola M, Davoli A, Rigoni A, Zenti MG, Pastorin AM, Lo Cascio V: E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress. Diabetologia 40:584-589, 1997
39. Cominacini L, Garbin U, Fratta Pasini A, Lo Cascio V: Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: a possible role of oxidized LDL (Letter). Diabetologia 39:1244, 1996
40. Fasching P, Waldhausl W, Wagner OF: Elevated circulating adhesion molecules in NIDDM: potential mediators in diabetic macroangiopathy Diabetologia 39:1242- 1244, 1996
41. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD: Increased levels of soluble adhesion molecules in type 2 (non- insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979-984, 1994
42. Tanaka S, Seino H, Satoh J, Fujii N, Rikiishi H, Zhu XP, Takahashi K, Sagara M, Nobunaga T, Toyota T: Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats, Clin Immunol Immunopathol 62:258-263, 1992
43. Nguyen P, Durlach V, Leutenegger M, Guenounou M, Potron G: Explosion respiratoire des polynucléaires neutrophiles et profil des cytokines chez le diabétique non insulin- odépendant. J Mol Vasc 20:102-105, 1995
44. Sekizuka K, Tomino Y, Sei C, Kurusu A, Tashiro K, Yamaguchi Y, Kodera S, Hishiki T, Shirato I, Koide H: Detection of serum IL-6 in patients with diabetic nephropathy Nephron 68:284-285, 1994
45. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240:1546-1548, 1988
46. Morohoshi M, Fujisawa K, Uchimura I, Numano F: The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann NY Acad Sci 748:562-570, 1995
47. Jovinge S, Ares MP, Kallin B, Nilsson J: Human monocytes/macrophages release tumor necrosis factor-α in response to oxidized-LDL. Arteriocler Thromb Vasc Biol 16:1573-1579, 1996
48. Cavender D, Saegusa Y, Ziff M: Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol 139:1855-1860, 1987
49. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA: Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 82:8667-8671, 1985
50. Ming WJ, Bersani L, Mantovani A: Tumor necrosis factor-α is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 138:1469-1474, 1987
51. Bevilacqua MP, Gimbrone MA: Inducible endothelial functions in inflammation and coagulation. Semin Thromb Hemost 13:425- 433, 1987
52. Raines EW, Ross R: Multiple growth factors are associated with lesions of atherosclerosis: specificity or redundancy? Bioessays 18:271-282, 1996